机译:ⅠⅠ/Ⅱ研究蒂拉布替尼,第二代Bruton的酪氨酸激酶抑制剂,复发/难治原发性中枢神经系统淋巴瘤
Natl Canc Ctr Dept Neurosurg & Neurooncol Tokyo Japan;
Kyorin Univ Dept Neurosurg Fac Med Tokyo Japan;
Saitama Med Univ Dept Neurooncol Neurosurg Int Med Ctr Saitama Japan;
Japanese Fdn Canc Res Canc Inst Hosp Dept Hematol & Oncol Tokyo Japan;
Kyoto Univ Dept Neurosurg Grad Sch Med Kyoto Japan;
Kagoshima Univ Hosp Dept Neurosurg Kagoshima Japan;
Osaka Int Canc Inst Dept Neurosurg Osaka Japan;
Tohoku Univ Dept Hematol & Rheumatol Grad Sch Med Sendai Miyagi Japan;
Hiroshima Univ Hosp Dept Med Oncol Hiroshima Japan;
Kumamoto Univ Hosp Dept Neurosurg Kumamoto Japan;
Ono Pharmaceut Co Ltd Osaka Japan;
Ono Pharmaceut Co Ltd Osaka Japan;
Saitama Med Univ Dept Neurooncol Neurosurg Int Med Ctr Saitama Japan;
Bruton's tyrosine kinase; CARD11; MYD88; primary central nervous system lymphoma; tirabrutinib;